Sökresultat

I Drupal kan du arbeta med bilder, videor och annan media som exempelvis radioklipp, podcasts och dokument. På den här sidan hittar du information och instruktioner i hur du gör för att ladda upp eller bädda in media samt vad du behöver tänka på när du gör det. Menyn "Media"Här listas alla dina bilder, videor och övriga filer. Du når "Media" genom att gå till Content > Files and media > List all m

https://www.webbpublicering.lu.se/innehall/skapa-redigera-och-publicera-innehall/bild-video-dokument-och-annan-media - 2026-09-11

Personallistan på sidan people list är en automatiskt genererad lista, som listar de personer du skapat personliga sidor till. Sidan kommer med en inbyggd sökfunktion där dina besökare kan söka efter personal samt filtrera visning av personal efter kategorier. Du som är site administrator skapar kategorier som medarbetare sedan kan välja att märka upp sina personliga sidor med. När du är inloggad

https://www.webbpublicering.lu.se/innehall/skapa-redigera-och-publicera-innehall/innehallstyper/sidor/personlig-sida/listning-av-personliga-sidor - 2026-09-11

I Drupal finns det ett flertal olika typer av innehåll du kan arbeta med. På den här sidan hittar du en sammanfattning av alla innehållstyperna och länkar till sidor där du kan fördjupa dig mer om varje innehållstyp. SidorI Drupal arbetar du med sidor för att bygga upp webbplatsens informationsstruktur. Det finns flera olika typer av sidor du kan arbeta med för att skapa innehåll:LandningssidorUnd

https://www.webbpublicering.lu.se/innehall/skapa-redigera-och-publicera-innehall/innehallstyper - 2026-09-11

Allt material som du skapar i Drupal vill du kanske inte publicera för allmän beskådan direkt. I det här avsnittet ska vi titta på hur du kan jobba med utkast, samt schemalägga datum och tid för publicering och avpublicering. Informationen i den här texten kan du tillämpa på undersidor, artiklar och evenemang. Publiceringsstatus för innehållNär du skapar innehåll i Drupal finns det tre olika statu

https://www.webbpublicering.lu.se/innehall/skapa-redigera-och-publicera-innehall/publiceringsstatus-schemalaggning-och-revisioner - 2026-09-11

Gunilla Westergren-Thorsson Director Email: gunilla [dot] westergren-thorsson [at] med [dot] lu [dot] se Telephone: +46 46 222 86 95 Mobile: +46 70 594 63 60 Kristian Pietras Co-director Email: kristian [dot] pietras [at] med [dot] lu [dot] se Telephone: +46 46 222 05 80 Lisa Rydén Clinical Co-Director Email: lisa [dot] ryden [at] med [dot] lu [dot] se Lisa Karlsson Scientific Communicator and coo

https://www.wcmm.lu.se/wallenberg-center-molecular-medicine-lund/management - 2026-09-11

What is WCMM Fusion 2025?This exhibition invites you to explore the fascinating intersection of science and art through stunning medical images created by the talented WCMM scientists. Each artwork tells a unique story of ongoing research, how it contributes to advancing scientific knowledge or addresses a specific medical need, and how far the research is with the goal of ultimately impacting cli

https://www.wcmm.lu.se/whats/wcmm-fusion-2025-where-science-meets-art - 2026-09-11

Postdoctoral program designed to foster cutting-edge translational research WCMM Lund is taking a significant step forward in training the new generation of young international, highly qualified postdoc candidates within the field of regenerative medicine with the launch of its IGNITE Postdoc Fellow Program. This initiative, funded by the Wallenberg Foundation, aims to support postdoctoral researc

https://www.wcmm.lu.se/ignite-postdoc-fellow-program - 2026-09-11

Cancer is a worldwide health challenge leading to increased mortality and diminishing quality of life of millions of people. In recent years, immunotherapy has transformed cancer treatment, but targeting effectively refractory solid tumours remains a challenge due to poor T cell activation. Downregulation of antigen presentation pathways and lack of professional antigen presenting cells in the tum

https://www.wcmm.lu.se/driving-tumor-antigen-presentation-rna-mediated-transdifferentiation - 2026-09-11

The emergence of induced pluripotent stem cells (iPS) has offered unprecedented opportunities in developmental biology and regenerative medicine. Generated from patient cells, iPS maintains their genetic features, allowing deciphering healthy or pathological processes in a personalized fashion. Applied to hematopoiesis, this technology holds enormous promises towards generating transplantable hema

https://www.wcmm.lu.se/human-ossicles-ips-hsc-development-and-leukemia-modeling - 2026-09-11

Introduction | Chronic inflammation in autoimmune diseases is driven by resident T cells and a breakdown in immune tolerance. Systemic factors often complicate the study of local antigen presentation; however, juvenile idiopathic arthritis (JIA) provides a unique model due to its joint-specific inflammation. While innate immune-driven T-cell activation has been observed in JIA, the roles of autoan

https://www.wcmm.lu.se/local-breach-tolerance-understanding-process-chronicity-autoimmune-disease - 2026-09-11

Why only certain animal species can regenerate complex structures remains an important and open question. Technological advances have now opened the door to studying the molecular mechanisms of highly regenerative species, like salamanders. A unique aspect of regeneration in these species is that fully differentiated cells are coaxed to re-enter the cell cycle. This reentry is typically blocked by

https://www.wcmm.lu.se/elucidating-underlying-mechanisms-cell-cycle-regulation-limb-regeneration - 2026-09-11

Multi-drug resistant bacterial infections, such as Pseudomonas aeruginosa represent a significant global health care burden and disproportionately impact patients who are immuno-comprised, which make them more susceptible to opportunistic pathogens. These infections impact a broad range of patients, including those with chronic diseases such as diabetes, cancer, organ transplant recipients, and th

https://www.wcmm.lu.se/apical-out-human-airway-organoids-chip-derived-ipscs-studying-bacterial-infections - 2026-09-11

Lung transplantation is currently the only treatment option for end-stage lung disease. Despite procedural improvements, primary graft dysfunction (PGD) remains a leading cause of early mortality and chronic allograft dysfunction, leading to poor long-term survival rates. Mesenchymal stem/stromal cell (MSC) based therapies have the potential to ameliorate injured donor lungs and to improve the res

https://www.wcmm.lu.se/advanced-engineered-msc-therapies-lung-transplantation - 2026-09-11

RNA based therapeutics, e.g., siRNA, antisense, mRNA- and CRISPR-based drugs, are a novel class of drugs that that are potential ideal precision drugs for oncology given their highly specific and targeted nature. However, cytosolic delivery remains the major obstacle to macromolecular RNA drug development.In my (Anders Wittrup) lab we have developed several new techniques both for detection and qu

https://www.wcmm.lu.se/discovery-and-characterization-cell-biological-barriers-therapeutic-rna-delivery - 2026-09-11

Back to news archive2017-11-30: Grants awarded from the Swedish Research Council (VR) and the Swedish Cancer Society (Cancerfonden)Congratulations to the following WCMM researchers who have recently received grants:ANJA MEISSNER, who received 800 tKr/year (2018-2020) from the Swedish Research Council (VR-M) for the project “The communication between Sphingosine-1-phosphate signaling and the Renin-

https://www.wcmm.lu.se/grant-award - 2026-09-11

Type 2 diabetes mellitus (T2D) and Parkinson’s Disease (PD) are two major disorders associated with aging, and their prevalence is steadily increasing worldwide. These two conditions share several important features: they have a complex multifactorial pathogenesis, encompass different disease subtypes, and are associated with degenerative changes in several organs. Individuals with T2D are reporte

https://www.wcmm.lu.se/translational-development-interface-between-diabetes-and-parkinsons-disease - 2026-09-11

Congential heart disease affects approximately one percent of all children born worldwide. This multidisciplinary project will combine novel 3D imaging, using synchrotron-based phase contrast micro-CT, with cell and molecular biology for improved understanding of congenital heart defects and cardiovascular function. The primary focus will be the importance of basement membranes for cardiovascular

https://www.wcmm.lu.se/importance-basement-membranes-cardiovascular-development-and-disease - 2026-09-11

Purpose | Our study seeks to contribute novel insights into the development of novel HSC-based regenerative strategies for multiple sclerosis (MS) using our recently defined connection point between peripheral and-CNS immunity. We aim to develop a better mechanistic understanding of this autologous cell therapy, keeping clinical translation in mind, thereby offering new hope for individuals affect

https://www.wcmm.lu.se/autologous-bone-marrow-transplantation-treatment-multiple-sclerosis-endogenous-hematopoietic-stem - 2026-09-11

The Stars of the Brain Iben Lundgaard, Associate Professor | LUNDGAARD LAB Through Synchrotron Eyes: A Glimpse into Early Heart Development Niccolò Peruzzi, Postdoc | TRAN LUNDMARK LAB Alpha Synuclein Galaxy Oksana Tymoshchuk, Research Associate | LUNDGAARD LAB Shortcut Karin Tran Lundmark, Principal Investigator | TRAN LUNDMARK LAB Developing Chick Embryo Nika Gvazava, PhD student | WAGNER LAB Au

https://www.wcmm.lu.se/whats/wcmm-fusion-2025-where-science-meets-art/where-science-meets-art - 2026-09-11

Back to news archiveTandem researchers Smith & MeissnerRead about Gustav Smith and Anja Meissner in LUM magasin nr 6, 2017 .

https://www.wcmm.lu.se/tandem-researchers-smith-meissner - 2026-09-11